Sato M, Han Q, Mori R, Mizuta K, et al. Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant Methion Anticancer Res 2024;44:1499-1504.
PMID: 38538002